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Background/Aims: Ulcerative colitis (UC), a type of inﬂammatory bowel
disease, is characterised by colonic inﬂammation and ulceration. Orally-
administered Emu Oil (EO), extracted from Emu fat, accelerated the in-
testinal repair process in a pre-clinical model of acuteUC.We hypothesized
that EO would reduce the severity of dextran sulphate sodium (DSS)-
induced chronic UC in mice.
Methods: Female C57BL/6mice (n¼ 10/group)were gavagedwithwater or
EO (80 mL or 160 mL) thrice weekly. Mice were subjected to two cycles each
consisting of ad libitum access to water or DSS (2% w/v) for one week and
two weeks water recovery. Followed by one week water or DSS and mice
culled two days later. Bodyweight, blood proﬁle, organ data and myelo-
peroxidase activity were assessed. p < 0.05 was considered signiﬁcant.
Results: DSS decreased bodyweight (days 6-19 and 26-30; maximum of
24%), compared to normal controls (p < 0.001). In DSS-treated mice, high
dose EO signiﬁcantly increased bodyweight (days 6-12), compared to
controls (p < 0.05). DSS decreased red blood cell count, compared to
normal controls (p < 0.05); an effect not improved by EO. Compared to
normal controls, DSS increased liver (16%), spleen (45%), lung (19%) and
small intestine (20%) weights (p < 0.05), although EO had no signiﬁcant
effect (p > 0.05). DSS increased colon myeloperoxidase activity compared
to normal controls (p < 0.05), however, EO was unable to signiﬁcantly
reduce these levels.
Conclusions: EO prevented bodyweight loss in this mouse model of
chronic colitis, however, was unable to improve other preliminary pa-
rameters. Analyses currently underway include chronic inﬂammatory
markers, histological morphometry and cell kinetics.
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Background/Aims: Over-consumption of dietary AGEs, which are formed
by heat-treatment of foodstuffs, is thought to lead to CKD. Research sug-
gests that AGEs maymodulate gut microbiota. The aim of this study was to
characterise the effects of dietary AGEs on gut homeostasis and CKD.
Methods: Male C57BL/6 mice 6-8 weeks old were fed (ad libitum) a low
AGE diet (unbaked rodent chow, LAGE) (n ¼ 10-20) or a high AGE diet
(baked rodent chow, 160 degrees C for 1h, 5-fold higher AGE content,
HAGE) (n ¼ 10-16) for 24 weeks. Urine albumin was measured by ELISA.
Expression of the tight junction protein occludin was determined in
jejunum by qPCR. Plasma endotoxin was measured using the Limulus
Amebocyte Lysate assay. 16S rRNA sequencing of caecal extracts was used
to proﬁle the gut microbiome.
Results: Chronic consumption of dietary AGEs led to increased caecal
bacterial diversity (LAGE vs. HAGE, mean ± SEM, 0.86 ± 0.02 vs. 0.95 ± 0,
Simpson diversity index, p¼ 0.0002) and decreased occludin expression in
the jejunum (1.17 ± 0.23 vs. 0.43 ± 0.08 fold change, p ¼ 0.003). Plasma
endotoxin was increased after high AGE feeding (1.45 ± 0.12 vs. 1.91 ± 0.14
EU/mL, p ¼ 0.028). The HAGE diet increased urinary albumin excretion
(36.04 ± 3.55 vs. 59.61 ± 4.05 mg/24 hours, p ¼ 0.0003).
Conclusions: These data indicate that excess consumption of AGEs leads to
albuminuria, which is associated with increased intestinal permeability
and alterations in gut microbiome. This association remains to be fully
deﬁned. Further studies in this area are warranted.
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Background/Aims: Breath hydrogen testing is useful to assess colonic
fermentation of malabsorbed carbohydrates and their role in symptom
genesis. Speciﬁcally, lactulose and fructose breath responses can guide
dietary restriction of FODMAPs (fermentable carbohydrates) in patients
with irritable bowel syndrome (IBS). However, data regarding their
reproducibility is limited. The aimwas to investigate the reproducibility of
lactulose and fructose breath tests.
Methods: A retrospective audit was conducted in 27 IBS patients
completing a 15 g lactulose breath test and in 32 patients ingesting 35 g
fructose. A repeat test was performed 6-8 weeks later for lactulose and 6
weeks for fructose. Changes in responses between test and retest were
analysed qualitatively [positive response: 2 10 ppm hydrogen rise) and
quantitatively as area-under-curve (AUC)] and oro-caecal transit time
(OCTT). The effect of duration between testing and variability was also
assessed.
Results: A positive lactulose response was maintained in 96% subjects, but
31% (p ¼ 0.0006) lost a positive fructose response upon retest. Initial
hydrogen AUC to lactulose and fructose were poorly correlated with
hydrogen AUC values on repeat testing (lactulose: r2 ¼ 0.08, p ¼ 0.16;
fructose: r2 ¼ 0.07, p ¼ 0.18; regression analysis). Such variations in fruc-
tose responses was independent of the duration between test and retest
(r2 ¼ 0.003, p ¼ 0.82. Lactulose OCTT (r ¼ 0.29; p ¼ 0.15; Spearman's
correlation) or fructose (r ¼ 0.29; p ¼ 0.31) were not correlated between
test-retest.
Conclusions: Poor reproducibility of lactulose and fructose breath testing
was demonstrated. Making clinical decisions (e.g. malabsorptive diagnosis
or to guide dietary fructose restriction) on the results of a single test cannot
be justiﬁed.
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Background/Aims: Propolis is a resinous product collected by honeybees
from polyphenol-rich plants. It has documented antioxidant and anti-in-
ﬂammatory properties although its mechanisms of action are understood
poorly. In this study, the anti-inﬂammatory effects of polyphenol-rich
propolis extracts (PPE) from China (CPPE) and Brazil (BPPE) were
examined.
Methods: FolineCiocalteu’s method and chromatographic analysis were
used to compare their chemical compositions and in vitro antioxidant
activities were measured using several different indices. The anti-inﬂam-
matory effects of PPE from China and Brazil were examined in murine
endotoxin-induced inﬂammatory lung injury as well several cellular
inﬂammation models.
Results: CPPE and BPPE showed differences in their polyphenolic
composition and in vitro free radical scavenging activities. Oral adminis-
tration of PPE to lipopolysaccharide (LPS)-challenged mice decreased
serum proinﬂammatory cytokine concentrations and inhibited pulmonary
nuclear factor (NF)-kB activation. Both PPE types modulated LPS-induced
key inﬂammatory mediators and cytokine gene expression in RAW 264.7
macrophages. Reactive oxygen species (ROS) production and several in-
ﬂammatory mediators were suppressed by both PPE types in a time and
dose-dependent manner. In HeLa-T6RZC stable cells where NF-kB signal-
ling is initiated at the level of TNF receptor-associated factor 6 (TRAF6), we
found PPE suppressed NF-kB activation by delaying the ubiquitination of
TRAF6. In an in vitro kinase assay system, both PPE types directly disrupted
polyubiquitin synthesis by TRAF6.
